The stock price performance for the year has been a mixed bag, indicating either a pessimistic or optimistic outlook depending on how you look at it. Year to date metric has recorded a loss of -65.76%.However, over the last six months, we can see a stronger performance of -98.58%. Over the last 30 days, the price of WINT has leaped by -64.72%. And in the last five days, it has fallen by -15.66%.
Windtree Therapeutics Inc experienced a rather shaky stock market performance. The highest value in the past year was recorded at $14.75 on 08/07/24 and the lowest value was $0.12 on 02/04/25.
52-week price history of WINT Stock
Analyzing a stock’s 52-week high and low prices can offer important information about its present condition and future outlook. Windtree Therapeutics Inc’s current trading price is -99.19% away from its 52-week high, while its distance from the 52-week low is -1.32%. The stock’s price range during this period has varied between$0.12 and $14.75. The Windtree Therapeutics Inc’s shares, which operate in the Healthcare, saw a trading volume of around 7.0 million for the day, a figure considerably higher than their average daily volume of 3.25 million over last three months.
Market Capitalization vs. Financial Performance: A Comparative Study
Windtree Therapeutics Inc (WINT) has experienced a quarterly decline of -83.00% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 1.32M and boasts a workforce of 15 employees.
Combining Moving Average and Trading Volume Data for Better Market Insight
Based on Barchart.com data, the company’s moving average over the 100-day period was 0.8785, with a change in price of -2.9404. Similarly, Windtree Therapeutics Inc recorded 2,922,600 in trading volume during the last 100 days, posting a change of -96.09%.
WINT’s Debt-to-Equity Ratio Cause for Concern? An In-Depth Look
The debt-to-equity (D/E) ratio is a significant metric that provides insights into a company’s financial state and market presence. By dividing a company’s current liabilities by its shareholders’ equity, the D/E ratio depicts the extent of debt used by a company to fund its assets relative to the value of its shareholders’ equity. At the time of writing, the total D/E ratio for WINT stands at 1.68. Similarly, the long-term debt-to-equity ratio is also 0.12.
WINT Stock Stochastic Average
Windtree Therapeutics Inc’s raw stochastic average for the past 50 days is presently 2.93%, as of today. This marks a decrease from the raw stochastic average of the last 20 days, which was 6.52%. Additionally, the company’s Stochastic %K and %D values for the past 20 days were 3.32% and 2.99%, respectively.
